Skip to main content

Opill FDA Approval History

Last updated by Judith Stewart, BPharm on July 13, 2023.

FDA Approved: Yes (First approved July 13, 2023)
Brand name: Opill
Generic name: norgestrel
Dosage form: Tablets
Company: Perrigo Company
Treatment for: Birth Control

Opill (norgestrel) is a progestin-only, over-the-counter birth control pill for the prevention of pregnancy.

Development timeline for Opill

DateArticle
Jul 13, 2023Approval FDA Approves Opill (norgestrel) OTC Daily Oral Contraceptive
Oct 26, 2022Perrigo Receives Notification of Postponement for Joint FDA Advisory Committee to Review OpillĀ® Daily Oral Contraceptive for Over-The-Counter (OTC) Use
Jul 11, 2022Perrigo's HRA Pharma Submits Application to FDA for First-Ever OTC Birth Control Pill

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.